131 related articles for article (PubMed ID: 12187076)
1. 5'-End RET splicing: absence of variants in normal tissues and intron retention in pheochromocytomas.
Le Hir H; Charlet-Berguerand N; de Franciscis V; Thermes C
Oncology; 2002; 63(1):84-91. PubMed ID: 12187076
[TBL] [Abstract][Full Text] [Related]
2. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function.
Carter MT; Yome JL; Marcil MN; Martin CA; Vanhorne JB; Mulligan LM
Cytogenet Cell Genet; 2001; 95(3-4):169-76. PubMed ID: 12063395
[TBL] [Abstract][Full Text] [Related]
3. Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas.
Le Hir H; Charlet-Berguerand N; Gimenez-Roqueplo A; Mannelli M; Plouin P; de Franciscis V; Thermes C
Oncology; 2000 May; 58(4):311-8. PubMed ID: 10838497
[TBL] [Abstract][Full Text] [Related]
4. Expression of RET 3' splicing variants during human kidney development.
Ivanchuk SM; Myers SM; Mulligan LM
Oncogene; 1998 Feb; 16(8):991-6. PubMed ID: 9519873
[TBL] [Abstract][Full Text] [Related]
5. Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis.
de Graaff E; Srinivas S; Kilkenny C; D'Agati V; Mankoo BS; Costantini F; Pachnis V
Genes Dev; 2001 Sep; 15(18):2433-44. PubMed ID: 11562352
[TBL] [Abstract][Full Text] [Related]
6. Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.
Myers SM; Eng C; Ponder BA; Mulligan LM
Oncogene; 1995 Nov; 11(10):2039-45. PubMed ID: 7478523
[TBL] [Abstract][Full Text] [Related]
7. High levels of tyrosine phosphorylated proto-ret in sporadic phenochromocytomas.
Le Hir H; Colucci-D'Amato LG; Charlet-Berguerand N; Plouin PF; Bertagna X; de Franciscis V; Thermes C
Cancer Res; 2000 Mar; 60(5):1365-70. PubMed ID: 10728700
[TBL] [Abstract][Full Text] [Related]
8. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
9. 3' Splicing variants of ret receptor tyrosine kinase are differentially expressed in mouse embryos and in adult mice.
Lee KY; Samy ET; Sham MH; Tam PK; Lui VC
Biochim Biophys Acta; 2003 May; 1627(1):26-38. PubMed ID: 12759189
[TBL] [Abstract][Full Text] [Related]
10. Expression of the RET proto-oncogene in normal human tissues, pheochromocytomas, and other tumors of neural crest origin.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
J Mol Med (Berl); 1996 Oct; 74(10):617-21. PubMed ID: 8912182
[TBL] [Abstract][Full Text] [Related]
11. The RET proto-oncogene in sporadic pheochromocytomas.
Takaya K; Yoshimasa T; Arai H; Tamura N; Miyamoto Y; Itoh H; Nakao K
Intern Med; 1996 Jun; 35(6):449-52. PubMed ID: 8835594
[TBL] [Abstract][Full Text] [Related]
12. RET receptor tyrosine kinase isoforms in kidney function and disease.
Lee DC; Chan KW; Chan SY
Oncogene; 2002 Aug; 21(36):5582-92. PubMed ID: 12165857
[TBL] [Abstract][Full Text] [Related]
13. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the RET protooncogene in sporadic pheochromocytomas.
Lindor NM; Honchel R; Khosla S; Thibodeau SN
J Clin Endocrinol Metab; 1995 Feb; 80(2):627-9. PubMed ID: 7852530
[TBL] [Abstract][Full Text] [Related]
15. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
16. Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.
Scott RP; Eketjäll S; Aineskog H; Ibáñez CF
J Biol Chem; 2005 Apr; 280(14):13442-9. PubMed ID: 15677445
[TBL] [Abstract][Full Text] [Related]
17. cDNA sequence and genomic structure of the rat RET proto-oncogene.
Matera I; De Miguel-Rodríguez M; Fernández-Santos JM; Santamaria G; Puliti A; Ravazzolo R; Romeo G; Galera-Davidson H; Ceccherini I
DNA Seq; 2000; 11(5):405-17. PubMed ID: 11328649
[TBL] [Abstract][Full Text] [Related]
18. Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.
Lorenzo MJ; Eng C; Mulligan LM; Stonehouse TJ; Healey CS; Ponder BA; Smith DP
Oncogene; 1995 Apr; 10(7):1377-83. PubMed ID: 7731689
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas.
Edström E; Frisk T; Farnebo F; Höög A; Bäckdahl M; Larsson C
Int J Mol Med; 2000 Oct; 6(4):469-74. PubMed ID: 10998441
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
Nakata T; Yokota T; Emi M; Minami S
Genes Chromosomes Cancer; 2002 Sep; 35(1):30-7. PubMed ID: 12203787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
